Categories: Health Care

Hairline International Unveils Rigenera Activa – A Procedure for Autologous Skin Micrografting, for the first ime in India

Bangalore, April 12, 2018: Hairline International Hair and Skin Clinic has been working tirelessly in the field of regenerative therapies for hair and skin and is today proud to unveil RigeneraActiva, a specialized technology imported from Italy to launch autologous skin micrografting in the treatment of male and female pattern hair loss for the first time in India.

This therapy makes use of tissue from a patient to create an ideal cocktail of growth enhancement cells that is introduced into the scalp or the skin to encourage hair growth. The process involves just one sitting and results can be seen as early as within a month.RigeneraActiva is approved by the US FDA, Japan’s PMPD and is CE certified.

Speaking at the unveiling of RigeneraActiva, Dr. BaniAnand, Founder and Director, Hairline International Hair and Skin Clinic says, “This is a standalone procedure and can be used for treating hair loss up to Grade 4. For skin, the process of injecting takes about 20 minutes and the recovery time is around half hour, making it an ideal procedure. The procedure itself is completed in one sitting of not more than 30 minutes and results can be seen as early as within a month. Follow-ups are required just once a year for a short while. This procedure works for anyone above 21 years of age”.

Explaining the procedure that is scientifically known as stromal vascular fraction, Dr. Dinesh G Gowda, Senior Dermato-surgeon, Hairline International Hair and Skin Clinic explains, “Whether for hair or for skin, the epidermal layer is removed and around 2mm of the patient’s own tissuefrom the dermis, including fat is taken out. This tissue contains many growth factors and progenitor cells among other components. This is pulverized in a specialized machine and then is subject to filtration using a biological filter. This separates the progenitor cells, growth factors such as endothelial growth factors, fibroblast hair follicles etc.,which support hair follicles and skin cells – for growth as well as formation of new hair follicles and skin cells”.

Dr. Gowda adds that this cocktail of growth enhancers is injected via a thin needle into the scalp or the skin at areas needed. The process may be repeated in a year if needed for skin and if one would like a dense growth of hair.

Elaborating on the benefits of such a process, Dr. Gowda explains, “While hair transplant remains the best form of therapy, this therapy makes use of the patient’s own tissue to create an effective cocktail and works better than individual growth factors which are used. This therapy may be used alone or with hair transplant. It may be used with PRP as well.

Some other beneficial applications of the therapy are in the treatment of scars, Vitiligo, wound healing and face rejuvenation as well and stretch marks”.

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Lung Cancer Awareness Month

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

13 hours ago

Unmasking COPD: The Silent Respiratory Threat of Smoking

By  Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital …

13 hours ago

Khazi India Foundation to Host Expert Cardiac Consultations in Adoni

Kurnool, November 20, 2024: Adoni, Andhra Pradesh, – The Khazi India Foundation is pleased to…

1 day ago

Aakash Healthcare Celebrates Children’s Day with Kids from Choti Si Khushi

New Delhi, November 20, 2024: Aakash Healthcare marked this year’s Children’s Day with a joyful…

1 day ago

Annual eye screening crucial for diabetic patients to protect eyesight: Dr Agarwals Eye Hospital

Dr Agarwals Eye Hospital, Bengaluru, is providing free consultations for diabetic patients aged 50 and…

4 days ago

7 Signs You Are Suffering From Protein Deficiency

By Ms. Archana S, Senior Nutritionist, Aster Whitefield Hospital, Bengaluru As an essential nutrient, protein…

4 days ago